Standard Biotools (LAB) Free Cash Flow Growth (1y) (2011 - 2026)
Standard Biotools (LAB) Free Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.02 Bn | 179.73 Bn | 6.27 Bn | -1.82% |
| 2 | Stryker | 132.13 Bn | 129.26 Bn | 3.81 Bn | 226.77% |
| 3 | Medtronic | 111.43 Bn | 102.21 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 68.97 Bn | 67.52 Bn | 3.61 Bn | -51.69% |
| 5 | Edwards Lifesciences | 48.31 Bn | 44.64 Bn | 1.29 Bn | -109.40% |
| 6 | Dexcom | 28.91 Bn | 27.79 Bn | 750.30 Mn | 363.84% |
| 7 | GE HealthCare Technologies | 28.86 Bn | 26.58 Bn | 1.98 Bn | -31.71% |
| 8 | Smith & Nephew | 28.12 Bn | 27.54 Bn | - | - |
| 9 | Koninklijke Philips | 24.33 Bn | 21.29 Bn | 2.01 Bn | 129.73% |
| 10 | Standard Biotools | 302.22 Mn | -152.96 Mn | 11.31 Mn | -32.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.77% |
| Dec 31, 2025 | 82.51% |
| Sep 30, 2025 | 32.54% |
| Jun 30, 2025 | 58.72% |
| Mar 31, 2025 | 44.14% |
| Dec 31, 2024 | 3.61% |
| Sep 30, 2024 | -166.64% |
| Jun 30, 2024 | -276.40% |
| Mar 31, 2024 | -566.21% |
| Dec 31, 2023 | 43.28% |
| Sep 30, 2023 | 52.40% |
| Jun 30, 2023 | 67.12% |
| Mar 31, 2023 | 42.31% |
| Dec 31, 2022 | -3,887.20% |
| Sep 30, 2022 | 48.10% |
| Jun 30, 2022 | 20.01% |
| Mar 31, 2022 | 16.98% |
| Dec 31, 2021 | 96.54% |
| Sep 30, 2021 | -909.72% |
| Jun 30, 2021 | -1,026.79% |